Literature DB >> 32206604

Hyperthyroidism.

Amanda R Doubleday1, Rebecca S Sippel1.   

Abstract

Hyperthyroidism is a condition where the thyroid gland produces and secretes inappropriately high amounts of thyroid hormone which can lead to thyrotoxicosis. The prevalence of hyperthyroidism in the United States is approximately 1.2%. There are many different causes of hyperthyroidism, and the most common causes include Graves' disease (GD), toxic multinodular goiter and toxic adenoma. The diagnosis can be made based on clinical findings and confirmed with biochemical tests and imaging techniques including ultrasound and radioactive iodine uptake scans. This condition impacts many different systems of the body including the integument, musculoskeletal, immune, ophthalmic, reproductive, gastrointestinal and cardiovascular systems. It is important to recognize common cardiovascular manifestations such as hypertension and tachycardia and to treat these patients with beta blockers. Early treatment of cardiovascular manifestations along with treatment of the hyperthyroidism can prevent significant cardiovascular events. Management options for hyperthyroidism include anti-thyroid medications, radioactive iodine, and surgery. Anti-thyroid medications are often used temporarily to treat thyrotoxicosis in preparation for more definitive treatment with radioactive iodine or surgery, but in select cases, patients can remain on antithyroid medications long-term. Radioactive iodine is a successful treatment for hyperthyroidism but should not be used in GD with ophthalmic manifestations. Recent studies have shown an increased concern for the development of secondary cancers as a result of radioactive iodine treatment. In the small percentage of patients who are not successfully treated with radioactive iodine, they can undergo re-treatment or surgery. Surgery includes a total thyroidectomy for GD and toxic multinodular goiters and a thyroid lobectomy for toxic adenomas. Surgery should be considered for those who have a concurrent cancer, in pregnancy, for compressive symptoms and in GD with ophthalmic manifestations. Surgery is cost effective with a high-volume surgeon. Preoperatively, patients should be on anti-thyroid medications to establish a euthyroid state and on beta blockers for any cardiovascular manifestations. Thyroid storm is a rare but life-threatening condition that can occur with thyrotoxicosis that must be treated with a multidisciplinary approach and ultimately, definitive treatment of the hyperthyroidism. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Graves’ disease (GD); Hyperthyroidism; radioactive iodine (RAI); surgery; toxic adenoma; toxic multinodular goiter

Year:  2020        PMID: 32206604      PMCID: PMC7082267          DOI: 10.21037/gs.2019.11.01

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  85 in total

1.  The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.

Authors:  H B Burch; B L Solomon; D S Cooper; P Ferguson; N Walpert; R Howard
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

Review 2.  Thyroid carcinoma in Graves' disease: A meta-analysis.

Authors:  Joy U L Staniforth; Senarath Erdirimanne; Guy D Eslick
Journal:  Int J Surg       Date:  2015-11-26       Impact factor: 6.071

3.  Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine.

Authors:  F Azizi; L Ataie; M Hedayati; Y Mehrabi; F Sheikholeslami
Journal:  Eur J Endocrinol       Date:  2005-05       Impact factor: 6.664

4.  A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.

Authors:  Vincenzo Di Donna; Mario Giannotti Santoro; Chiara de Waure; Maria Pia Ricciato; Rosa Maria Paragliola; Alfredo Pontecorvi; Salvatore Maria Corsello
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 5.  A systematic review of drug therapy for Graves' hyperthyroidism.

Authors:  Prakash Abraham; Alison Avenell; Christine M Park; Wendy A Watson; John S Bevan
Journal:  Eur J Endocrinol       Date:  2005-10       Impact factor: 6.664

6.  Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.

Authors:  Mads Lillevang-Johansen; Bo Abrahamsen; Henrik Løvendahl Jørgensen; Thomas Heiberg Brix; Laszlo Hegedüs
Journal:  Thyroid       Date:  2019-02-13       Impact factor: 6.568

7.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

Authors:  L Tallstedt; G Lundell; O Tørring; G Wallin; J G Ljunggren; H Blomgren; A Taube
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

8.  Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.

Authors:  Ivan Kruljac; Darko Solter; Ana Marija Vrkljan; Miljenko Solter
Journal:  Endocr Res       Date:  2014-05-15       Impact factor: 1.720

9.  Thyroid storm presenting as psychosis: masked by diabetic ketoacidosis.

Authors:  Raafia Memon; WuQiang Fan; Richard Snyder; Mahesh Krishnamurthy
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-09-07

Review 10.  Hypertension in Thyroid Disorders.

Authors:  Eszter Berta; Inez Lengyel; Sándor Halmi; Miklós Zrínyi; Annamária Erdei; Mariann Harangi; Dénes Páll; Endre V Nagy; Miklós Bodor
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-17       Impact factor: 5.555

View more
  6 in total

Review 1.  Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions.

Authors:  Nadia Sawicka-Gutaj; Natalia Zawalna; Paweł Gut; Marek Ruchała
Journal:  Pharmacol Rep       Date:  2022-06-30       Impact factor: 3.919

2.  Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan.

Authors:  Asim Munir Alvi; Umal Azmat; Waqas Shafiq; Abdul Hannan Ali Rasheed; Ahmed Imran Siddiqi; Sardar Khan; Sara Ashfaq; Hira Irfan; Humayun Bashir; Muhammad Abu Bakar; Kashif Asghar
Journal:  Cureus       Date:  2022-05-14

Review 3.  Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

Authors:  Kanchan Kumari; Gagan B N Chainy; Umakanta Subudhi
Journal:  Heliyon       Date:  2020-12-13

4.  Characteristics of thyrotoxicosis among thyroid patients and their quality of life in a teaching hospital in Jordan: A cross-sectional study.

Authors:  Sarah Ibrahim; Amani Al-Rawashdeh; Raja'a Al-Qudah; Muna Barakat; Abla Al-Bsoul
Journal:  Pharm Pract (Granada)       Date:  2022-01-17

5.  A hypothyroid mother after subtotal thyroidectomy delivered a newborn with hyperthyroidism from fetal stage: a case report.

Authors:  Cheng Peng; Weijie Sun; Lixin Fan; Li Li; Xiaojiao Zhang; Ying Gao; Xinlin Hou
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-12       Impact factor: 3.007

Review 6.  Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered.

Authors:  A Losada-García; S A Cortés-Ramírez; M Cruz-Burgos; M Morales-Pacheco; Carlos D Cruz-Hernández; Vanessa Gonzalez-Covarrubias; Carlos Perez-Plascencia; M A Cerbón; M Rodríguez-Dorantes
Journal:  Front Genet       Date:  2022-01-17       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.